The free dividend tracker to help you grow your wealth. Link your brokerage accounts and MerryDiv automatically syncs your holdings and dividends.
Data last updated: Jul 13, 2026
Snapshot (as of Jul 13, 2026): ResMed Inc. (RMD) pays a $2.40 annual dividend ($0.60 quarterly), yielding 1.18% at $203.87/share. Next ex-dividend date 2026-05-14. 12+ consecutive years of dividend growth. Source: Yahoo Finance, aggregated by MerryDiv.
Dividend Yield: 1.18%
Annual Dividend: $2.40 per share
Payout Ratio: 22.4%
Ex-Dividend Date: 2026-05-14
Dividend Frequency: quarterly
Sector: Healthcare
Years of Dividend History: 15
ResMed Inc. pays a dividend backed by a global medical device and software business spanning sleep apnea treatment, ventilation, and out-of-hospital care platforms like AirView and Brightree. The ResMed Inc. dividend currently yields 1.18%, with a trailing annual rate of $2.40 per share paid quarterly. The next ex-dividend date is May 14, 2026, with the last declared quarterly payment at $0.60 per share. At a beta of 0.775, RMD stock carries below-market volatility, which suits growth-and-income investors who can accept a low current yield in exchange for steady dividend expansion.
ResMed Inc. pays out 22.4% of earnings as dividends, a payout ratio classified as conservative (below 40%). That low retention of earnings reflects a business generating demand from recurring needs: sleep apnea patients require ongoing device use, and RMD's cloud-based platforms like myAir and MatrixCare create subscription-style engagement across roughly 140 countries. ResMed Inc. dividend safety looks well-supported at current payout levels, though any meaningful compression in device reimbursement rates or slower adoption of its SaaS segment would reduce the earnings base that keeps this ratio low.
ResMed Inc. dividend history shows a CAGR of 8.6% per year from 2013 to 2025. The per-share annual dividend grew from $0.84 in 2013 to $2.26 in 2025 (2026 is a partial year and excluded from this calculation). The smallest annual increase in the window was 2.6% in 2020, which shows that even in a slower year, RMD did not freeze the dividend. Twelve consecutive years of increases round out a picture of disciplined, uninterrupted growth rather than aggressive acceleration.
| Period | CAGR | From | To |
|---|---|---|---|
| 3-Year | +9.5% | $1.72 (2022) | $2.26 (2025) |
| 5-Year | +7.7% | $1.56 (2020) | $2.26 (2025) |
| 10-Year | +6.9% | $1.16 (2015) | $2.26 (2025) |
RMD stock fits growth-and-income investors who prioritize dividend expansion over immediate income. The yield is low (below 2%) at 1.18%, and that is the central trade-off: the current yield sits above its 5-year average of 0.93%, so income investors are getting a slightly better entry point on yield than the recent norm, but the absolute level remains modest. What ResMed Inc. offers instead is 12 consecutive years of increases at an 8.6% annual growth rate, backed by a 22.4% payout ratio that leaves ample room for further raises. The trade-off is clear: accept a low starting yield now, or look elsewhere for current income.
| Payment Date | Amount per Share |
|---|---|
| 2026-05-14 | $0.6000 |
| 2026-02-12 | $0.6000 |
| 2025-11-13 | $0.6000 |
| 2025-08-14 | $0.6000 |
| 2025-05-08 | $0.5300 |
| 2025-02-13 | $0.5300 |
| 2024-11-07 | $0.5300 |
| 2024-08-15 | $0.5300 |
| 2024-05-08 | $0.4800 |
| 2024-02-07 | $0.4800 |
| Year | Total Dividends |
|---|---|
| 2026 | $1.2000 |
| 2025 | $2.2600 |
| 2024 | $2.0200 |
| 2023 | $1.8400 |
| 2022 | $1.7200 |
Project income from RMD with the RMD dividend calculator or track your full portfolio with the dividend tracker.